SUNITINIB MALATE CAPSULE

The recommended dose of Sunitinib Malate capsule for pancreatic neuroendocrine tumors (pNET) is 37.5 mg taken orally once daily continuously without a scheduled off-treatment period.Sunitinib Malate capsule may be taken with or without food.

Sunitinib Malate capsule is Stored at 25°C (77°F); excursions permitted to 15-30°C (59-86°F).

Stop using sunitinib and call your doctor at once if you have a serious side effect such as:

• headache with chest pain and severe dizziness, fainting, fast or pounding heartbeats;
• feeling short of breath (even with mild exertion), swelling in your ankles or feet;
• sudden numbness or weakness, problems with vision, speech, or balance;
• numbness or tingly feeling around your mouth;